These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23826368)
1. Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell Protection. Peltzer N; Vanli G; Yang JY; Widmann C PLoS One; 2013; 8(6):e68123. PubMed ID: 23826368 [TBL] [Abstract][Full Text] [Related]
2. RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3. Cailliau K; Lescuyer A; Burnol AF; Cuesta-Marbán Á; Widmann C; Browaeys-Poly E J Biol Chem; 2015 Aug; 290(32):19653-65. PubMed ID: 26109071 [TBL] [Abstract][Full Text] [Related]
3. The activity of the anti-apoptotic fragment generated by the caspase-3/p120 RasGAP stress-sensing module displays strict Akt isoform specificity. Vanli G; Peltzer N; Dubuis G; Widmann C Cell Signal; 2014 Dec; 26(12):2992-7. PubMed ID: 25246356 [TBL] [Abstract][Full Text] [Related]
4. [Effects of Buzhong Yiqi decoction on expression of Bad, NF-κB, caspase-9, Survivin, and mTOR in nude mice with A549/DDP transplantation tumors]. Liu YL; Yi JL; Liu CY Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):725-730. PubMed ID: 28959844 [TBL] [Abstract][Full Text] [Related]
5. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Ye Q; Cai W; Zheng Y; Evers BM; She QB Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280 [TBL] [Abstract][Full Text] [Related]
7. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
8. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells. Roca H; Varsos ZS; Pienta KJ Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839 [TBL] [Abstract][Full Text] [Related]
9. Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1). Dennis MD; McGhee NK; Jefferson LS; Kimball SR Cell Signal; 2013 Dec; 25(12):2709-16. PubMed ID: 24018049 [TBL] [Abstract][Full Text] [Related]
10. Orexin/hypocretin activates mTOR complex 1 (mTORC1) via an Erk/Akt-independent and calcium-stimulated lysosome v-ATPase pathway. Wang Z; Liu S; Kakizaki M; Hirose Y; Ishikawa Y; Funato H; Yanagisawa M; Yu Y; Liu Q J Biol Chem; 2014 Nov; 289(46):31950-31959. PubMed ID: 25278019 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways. Xu C; Liu C; Liu L; Zhang R; Zhang H; Chen S; Luo Y; Chen L; Huang S Neuropharmacology; 2015 Oct; 97():35-45. PubMed ID: 26002629 [TBL] [Abstract][Full Text] [Related]
12. Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin. Abe A; Kokuba H Oncol Rep; 2013 Apr; 29(4):1333-42. PubMed ID: 23338618 [TBL] [Abstract][Full Text] [Related]
13. EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells. Wang H; Gambosova K; Cooper ZA; Holloway MP; Kassai A; Izquierdo D; Cleveland K; Boney CM; Altura RA BMC Mol Biol; 2010 Aug; 11():66. PubMed ID: 20807437 [TBL] [Abstract][Full Text] [Related]
14. Foxc2 enhances proliferation and inhibits apoptosis through activating Akt/mTORC1 signaling pathway in mouse preadipocytes. Gan L; Liu Z; Jin W; Zhou Z; Sun C J Lipid Res; 2015 Aug; 56(8):1471-80. PubMed ID: 26113535 [TBL] [Abstract][Full Text] [Related]
15. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. Fuchs BC; Finger RE; Onan MC; Bode BP Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400 [TBL] [Abstract][Full Text] [Related]
16. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression. Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583 [TBL] [Abstract][Full Text] [Related]
18. [Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells]. Guo RH; Wang TS; Chen XF; Huang ZH; Shu YQ Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):903-6. PubMed ID: 21223797 [TBL] [Abstract][Full Text] [Related]
19. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle. Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856 [TBL] [Abstract][Full Text] [Related]
20. Thimerosal-induced apoptosis in mouse C2C12 myoblast cells occurs through suppression of the PI3K/Akt/survivin pathway. Li WX; Chen SF; Chen LP; Yang GY; Li JT; Liu HZ; Zhu W PLoS One; 2012; 7(11):e49064. PubMed ID: 23145070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]